BTG Enters IVC Market With $150M Novate Bolt-On
The diversified UK firm is betting $20m upfront and up to $150m total on a novel inferior vena cava filter technology.
The diversified UK firm is betting $20m upfront and up to $150m total on a novel inferior vena cava filter technology.